Role of the P2Y12 gene polymorphism in platelet responsiveness to clopidogrel in healthy subjects [12]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 9, 2006, Pages 2096-2097

  Bura, A ^a,b   Bachelot Loza, C ^a,b   Dali Ali, F ^a   Aiach, M ^a,b,c   Gaussem, Pascale ^a,b,c  

^a INSERM   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PURINE P2Y12 RECEPTOR; VASODILATOR STIMULATED PHOSPHOPROTEIN; DRUG DERIVATIVE; P2RY12 PROTEIN, HUMAN; PURINE P2 RECEPTOR; TICLOPIDINE;

ADULT; BLOOD SAMPLING; CAUCASIAN; CONFOUNDING VARIABLE; CONTROLLED STUDY; DRUG RESPONSE; FLOW CYTOMETRY; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; LETTER; NORMAL HUMAN; PHOTOMETRY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; ADOLESCENT; ARTICLE; DRUG EFFECT; GENETICS; PHARMACOGENETICS;

ADOLESCENT; ADULT; HUMANS; PHARMACOGENETICS; PLATELET AGGREGATION; POLYMORPHISM, GENETIC; RECEPTORS, PURINERGIC P2; TICLOPIDINE;

EID: 33747181327     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02113.x     Document Type: Letter

References (9)

1. Savi P, Pereillo JM, Uzabiaga MF, Combalbert J, Picard C, Maffrand JP, Pascal M, Herbert JM. Identification and biological activity of the active metabolite of clopidogrel. Thromb Haemost 2000; 84: 891-6.
2. Caprie SC. A randomised, blinded, trial of clopidogrel vs. aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
3. Cattaneo M. Aspirin and clopidogrel: Efficacy, safety, and the issue of drug resistance. Arterioscler Thromb Vasc Biol 2004; 24: 1980-7.
4. Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: A review of the evidence. J Am Coll Cardiol 2005; 45: 1157-64.
5. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005; 45: 246-51.
6. Fontana P, Dupont A, Gandrille S, Bachelot-Loza C, Reny JL, Aiach M, Gaussem P. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 2003; 108: 989-95.
7. Fontana P, Gaussem P, Aiach M, Fiessinger JN, Emmerich J, Reny JL. P2Y12 H2 haplotype is associated with peripheral arterial disease. A case-control study. Circulation 2003; 108: 2971-3.
8. Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, Gachet C. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 2005; 3: 85-92.
9. Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, Hod H. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004; 109: 3171-5.